William E. Rote, Senior Vice President, R&D at Travere Therapeutics, Inc. (TVTX), sold 1,563 shares at $21.93 ($34K) on 2022-05-11, disclosed to the SEC on 2022-05-12.
Scheduled sale ($34k) by Senior Vice President, R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.52 | 813 | $17K | 51.5% |
| 2 | $21.93 | 750 | $16K | 48.5% |
| Total | $21.72 avg | 1,563 | $34K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-23 | $356K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $409K | — | Filing → |
| TVTX | SELL | 2025-12-29 | $2.4M | — | Filing → |